Categories
News

REMEDY project recognised by the European Commission’s Innovation Radar for three breakthrough innovations in regenerative architecture

The European Commission’s Innovation Radar has highlighted three pioneering innovations developed within the REMEDY project, positioning the initiative at the forefront of next-generation sustainable building technologies.

The REMEDY project (Archibiome tattoo for resistant, responsive, and resilient cities) has been recognised by the European Commission’s Innovation Radar, an initiative that identifies and promotes high-potential innovations emerging from EU-funded research and innovation projects. Innovation Radar plays an important role in showcasing Europe’s most promising research results by identifying breakthrough technologies, connecting innovators with stakeholders, and helping accelerate the transition of scientific discoveries into market-ready solutions with societal impact.

Led by the University of Primorska under the coordination of Dr Anna Sandak, the REMEDY project is developing a transformative approach to architecture by introducing the concept of probiotic architecture: buildings enhanced with engineered living materials that interact positively with their environment. REMEDY proposes the development of an archibiome tattoo – a new generation of living, high-resolution microbial inks that enable bespoke decoration and functionalisation of both new and existing building surfaces. Unlike conventional building materials, REMEDY’s engineered living systems are designed to provide active and adaptive functions, including improved environmental performance, microbial balance, carbon sequestration, oxygen production, and bioremediation.

The three innovations recognised by Innovation Radar are:
1. Engineered living material systems for bio-active and adaptive building surfaces.
2. Engineered microbial systems for air purification, CO₂ capture, and antimicrobial building applications.
3. Printable bio-coating platform for applying functional microbial layers to building surfaces.

The REMEDY consortium brings together expertise from leading academic and industrial partners. University of Primorska is the project coordinator, other partners are University of Ljubljana, Graz University of Technology, Tiger Coatings, Qres Technologies,and Xylotrade B.V.
Through this interdisciplinary collaboration, REMEDY aims to redefine the relationship between microorganisms and the built environment. By challenging the traditional perception of microbes as harmful agents, the project seeks to establish a new paradigm where microorganisms become active partners in creating healthier, more sustainable, and adaptive spaces.

“REMEDY represents a next step towards a future of regenerative architecture, where buildings are no longer passive structures, but living systems capable of interacting with and improving their surroundings,” said Dr Anna Sandak, REMEDY Project Coordinator from the University of Primorska.

The recognition by Innovation Radar highlights the scientific ambition and innovation potential of REMEDY, supporting its vision of initiating a microbial revolution in architecture and advancing Europe’s leadership in sustainable, bio-based technologies.

Categories
News

REMEDY team at the ELSA Summer School on Engineered Living Materials

Four members of the REMEDY consortium are participating in this year’s ELSA Summer School on Engineered Living Materials in Scotland.

Dr. Jakub Grzybek and Dr. Wojciech Pajerski from the University of Primorska, together with Christoph Lumetzberger and Pascal Schmuck from Tiger Coatings, are discussing about ethical, legal and societal dimensions of Engineered Living Materials (ELMs).

The Summer school is organised within the EIC Pathfinder ELMs Portfolio, held in Glasgow and at SCENE, the University of Glasgow’s retreat on the shores of Loch Lomond. The programme brings together researchers and industry representatives to foster interdisciplinary collaboration and responsible innovation.

The event provides an opportunity to exchange knowledge, strengthen collaboration between academia and industry, and support the responsible development of Engineered Living Materials.

Categories
News Newsletter

Read about REMEDY project activities in the latest newsletter

The REMEDY project partners prepared the second project newsletter, highlighting the latest activities and results.

Over the past months, REMEDY consortium has continued to advance its scientific and engagement activities. REMEDY is one of the partners in EIC’s Engineered Living Materials portfolio’s “ELMs LCA Starter Kit” (ELM-LCAKit) project, which was selected for funding by the European Innovation Council within the BOOST initiative.

In March project partners gathered and attended the General Assembly and the second progress meeting, held and organized by the Biotechnical Faculty, University of Ljubljana, where they review the progress and discussed about the next steps.


Beyond research, REMEDY is also shaping the policy that will support the future development and scale-up of Engineered Living Materials across Europe by leading the preparation of recommendations for the upcoming Advanced Materials Act and the European Biotech Act II.

The consortium is active in shaping regulatory landscape of ELMs and the consortium is preparing for the impact and exploitation of the project’s results by actively joining the European Commission’s Booster service.

REMEDY, funded by the European Union’s Horizon Europe programme (European Innovation Council), is led by University of Primorska, and includes partners from University of Ljubljana, Technical University of Graz, TIGER Coatings, Xylotrade B.V., and Qres Technologies.


Read the REMEDY newsletter and stay tuned with news about the project by visiting REMEDY website and LinkedIn!